Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-14

FDA Approved: CEQUA — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved CEQUA (cyclosporine ophthalmic solution) from Sun Pharmaceutical Industries as an original NDA for the treatment of dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cequa (cyclosporine ophthalmic solution)

Snippet

ORIG AP for CEQUA (CYCLOSPORINE)